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CorrectionIn the article by Nowak et al., entitled “Disease Progression Modeling to Evaluate the Effects of Enzyme Replacement Therapy on Kidney Function in Adult Patients with the Classic Phenotype of Fabry Disease”, published in Kidney and Blood Pressure Research, 2017;42:001-015 (DOI: 10.1159/000464312), is one error: 
On page 5, first paragraph, the sentence: „The median total cumulative dose of the patients receiving agalsidase-b was 0.93 ml/kg [0.83–1.10] and agalsidase-a 0.20 ml/kg [0.18–0.21].“Should be read as following: The median total cumulative dose of the patients receiving agalsidase-b was 0.93 mg/kg [0.83–1.10] and agalsidase-a 0.20 mg/kg [0.18–0.21].
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